mebendazole has been researched along with Arthritis, Juvenile Chronic in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on a population-based analysis, enterobiasis does not reduce risk for asthma, type 1 diabetes, arthritis, or inflammatory bowel disease." | 1.38 | Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. ( Bager, P; Melbye, M; Vinkel Hansen, A; Wohlfahrt, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bager, P | 1 |
| Vinkel Hansen, A | 1 |
| Wohlfahrt, J | 1 |
| Melbye, M | 1 |
1 other study available for mebendazole and Arthritis, Juvenile Chronic
| Article | Year |
|---|---|
Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study.
Topics: Adolescent; Animals; Antinematodal Agents; Arthritis, Juvenile; Asthma; Child; Child, Preschool; Coh | 2012 |